MLM vs NEM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
MLM exhibits a stable but mediocre financial health profile with a Piotroski F-Score of 4/9 and no available Altman Z-Score. The stock is severely overvalued, trading at $612.85, which is more than double its Graham Number ($247.45) and over five times its growth-based intrinsic value ($114.52). While revenue shows modest growth, earnings are trending downward both YoY (-4.10%) and Q/Q (-5.10%), creating a dangerous disconnect between price and fundamental performance. The bearish technical trend (0/100) further suggests a lack of market momentum to support these premium valuations.
Newmont Corporation presents a dichotomy between strong operational fundamentals and significant valuation premiums. While the Piotroski F-Score of 4/9 indicates stable health and the balance sheet is pristine with a Debt/Equity ratio of 0.17, the stock trades at a substantial premium to its Graham Number ($66.88) and Intrinsic Value ($44.73). Recent quarterly earnings beats are impressive, yet bearish insider sentiment and a 0/100 technical trend suggest a lack of immediate conviction from internal stakeholders and market momentum. The overall outlook is neutral as strong profitability is offset by overvaluation and negative insider signals.
Compare Another Pair
Related Comparisons
MLM vs NEM: Head-to-Head Comparison
This page compares Martin Marietta Materials, Inc. (MLM) and Newmont Corporation (NEM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.